## Clinical Diagnosis: Osteogenesis Imperfecta (OI) Type I — COL1A1 Mutation ### Pathophysiology of Blue Sclerae **Key Point:** Blue sclerae result from **reduced collagen fibril diameter and decreased collagen content**, not from abnormal collagen chemistry. The sclera becomes translucent because the collagen fibrils are thinner and less densely packed, allowing the underlying choroid (which is blue-pigmented) to show through. ### Mechanism in COL1A1 Mutations COL1A1 gene mutations in OI Type I typically cause: - **Quantitative defect:** reduced synthesis of normal Type I collagen (haploinsufficiency) - **Result:** fewer, thinner collagen fibrils per unit area - **Optical consequence:** light scatters differently through sparse, thin fibrils → blue appearance ### Clinical Features of OI Type I and Their Basis | Feature | Mechanism | |---------|----------| | **Blue sclerae** | Thin collagen fibrils → translucency → choroid visible | | **Recurrent fractures** | Reduced collagen content → weak bone matrix | | **Conductive hearing loss** | Ossicular chain ossification defect (Type I collagen in middle ear) | | **Discolored, worn teeth** | Defective dentin (Type I collagen-rich) | | **Ligamentous laxity** | Weak ligaments due to reduced collagen | ### Distinction from Other OI Types **High-Yield:** OI Type I (COL1A1 haploinsufficiency) produces **normal collagen of reduced quantity**. - Other OI types (II–IV) involve **abnormal collagen structure** (e.g., glycine substitutions in the Gly-X-Y repeat) - Those present with more severe skeletal deformity and often perinatal lethality **Mnemonic: BLUE SCLERAE in OI Type I = **B**iochemically normal, **L**ess quantity, **U**nderproduced, **E** = Eye transparency** ### Why NOT Hydroxylation or Lysine Incorporation Defects? **Clinical Pearl:** If proline hydroxylation were defective (as in scurvy or vitamin C deficiency), the collagen triple helix would be unstable and would not form properly. Patients would have acute bleeding, poor wound healing, and perifollicular hemorrhages—not the chronic skeletal fragility of OI Type I. Lysine incorporation defects would cause abnormal cross-linking, presenting as hypermobility and skin laxity (like EDS), not brittle bones. [cite:Robbins 10e Ch 3; Harrison 21e Ch 348]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.